Bristol-Myers Squibb Other Working Capital increased by 253.2% to $1.64B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 54.5%, from $1.06B to $1.64B.
Large fluctuations may indicate timing differences in tax payments, accruals, or other non-core operational shifts.
Captures the net impact of changes in operating assets and liabilities not categorized as accounts receivable, inventory...
Varies significantly by industry; peers with similar business models should show comparable trends in accrual management.
change_in_other_working_capital| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q3 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.07B | $191.00M | $46.00M | $1.06B | $59.00M | $608.00M | -$725.00M | $1.06B | -$1.07B | $1.64B |
| QoQ Change | — | -82.2% | -75.9% | >999% | -94.5% | +930.5% | -219.2% | +246.1% | -200.8% | +253.2% |
| YoY Change | — | — | — | -0.8% | +28.3% | -42.9% | — | +74.2% | -47.3% | +54.5% |